Pfizer Stock Rises as Outlook Rises After Earnings Beat

Pfizer bumped up its earnings guidance on Wednesday while reporting better financial results than expected as it works to regain investors’ confidence after a disastrous 2023. More notable was the increase in earnings guidance. “This increase takes into consideration both our improving line of sight to our cost savings target, and continued strength in our underlying business,” CFO David Denton said in prepared remarks distributed ahead of the company’s Wednesday morning investor call.